A detailed history of Org Wealth Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Org Wealth Partners, LLC holds 2,679 shares of GILD stock, worth $332,437. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,679
Previous 1,972 35.85%
Holding current value
$332,437
Previous $218,000 36.24%
% of portfolio
0.11%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$108.22 - $120.47 $76,511 - $85,172
707 Added 35.85%
2,679 $297,000
Q2 2025

Jul 16, 2025

BUY
$96.91 - $113.0 $62,022 - $72,320
640 Added 48.05%
1,972 $218,000
Q1 2025

Apr 21, 2025

SELL
$89.14 - $117.41 $95,290 - $125,511
-1,069 Reduced 44.52%
1,332 $149,000
Q4 2024

Jan 10, 2025

BUY
$83.95 - $97.9 $91,421 - $106,613
1,089 Added 83.0%
2,401 $221,000
Q3 2024

Oct 11, 2024

BUY
$66.59 - $83.99 $87,366 - $110,194
1,312 New
1,312 $110 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Org Wealth Partners, LLC Portfolio

Follow Org Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Wealth Partners, LLC with notifications on news.